Denali Therapeutics Inc. (DNLI) financial statements (2021 and earlier)

Company profile

Business Address 161 OYSTER POINT BLVD.
SOUTH SAN FRANCISCO, CA 94080
State of Incorp. DE
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1,470415464
Cash and cash equivalents5077977
Short-term investments963336387
Receivables6 1
Prepaid expense  1
Other undisclosed current assets201514
Total current assets:1,496430481
Noncurrent Assets
Operating lease, right-of-use asset3334
Property, plant and equipment414725
Long-term investments and receivables3340148
Long-term investments3340148
Other noncurrent assets238
Total noncurrent assets:109123181
TOTAL ASSETS:1,604553662
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1320
Accounts payable132
Accrued liabilities  9
Employee-related liabilities  10
Deferred revenue2019
Deferred rent credit  1
Contract with customer, liability11
Other liabilities47240
Other undisclosed current liabilities4  
Total current liabilities:724533
Noncurrent Liabilities
Long-term debt and lease obligation6469 
Operating lease, liability6469
Liabilities, other than long-term debt244482
Deferred revenue2344
Contract with customer, liability57
Deferred rent credit  25
Other liabilities100
Other undisclosed noncurrent liabilities294  
Total noncurrent liabilities:38211382
Total liabilities:454158115
Stockholders' equity
Stockholders' equity attributable to parent1,151395547
Common stock211
Additional paid in capital1,504819774
Accumulated other comprehensive income (loss)(0)0(1)
Accumulated deficit(354)(426)(228)
Total stockholders' equity:1,151395547
TOTAL LIABILITIES AND EQUITY:1,604553662

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
Revenue from related parties307  
Gross profit:33627129
Operating expenses(273)(240)(176)
Operating income (loss):63(213)(46)
Nonoperating income91510
Investment income, nonoperating(0)53
Income (loss) from continuing operations before income taxes:72(198)(36)
Income tax benefit10 
Net income (loss):73(198)(36)
Other undisclosed net loss attributable to parent(2)  
Net income (loss) available to common stockholders, diluted:71(198)(36)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
Net income (loss):73(198)(36)
Comprehensive income (loss):73(198)(36)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(2)1(0)
Comprehensive income (loss), net of tax, attributable to parent:71(197)(37)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: